Showing results (11-20 of 85) with videos related to
Sort By:
Pageof 9
International Journal of Antimicrobial Agents|July 6, 2015
Ceftolozane/tazobactam and ceftazidime/avibactam: two novel β-lactam/β-lactamase inhibitor combination agents for the treatment of resistant Gram-negative bacterial infectionsJordan L Liscio, Monica V Mahoney, Elizabeth B HirschVirulence|September 3, 2016
Pharmacodynamic and pharmacokinetic considerations in the treatment of critically Ill patients infected with carbapenem-resistant EnterobacteriaceaeElizabeth A Neuner, Jason C GallagherPharmacotherapy|April 22, 2018
Shortened Courses of Antibiotics for Bacterial Infections: A Systematic Review of Randomized Controlled TrialsAlexandra M Hanretty, Jason C GallagherInfection and Drug Resistance|December 3, 2020
A Clinical Review and Critical Evaluation of Imipenem-Relebactam: Evidence to DateToni A Campanella, Jason C GallagherAntimicrobial Agents and Chemotherapy|November 11, 2015
Ertapenem-Containing Double-Carbapenem Therapy for Treatment of Infections Caused by Carbapenem-Resistant Klebsiella pneumoniaeJessica B Cprek, Jason C GallagherThe Annals of Pharmacotherapy|July 11, 2008
Tigecycline for the treatment of Acinetobacter infections: a case seriesJason C Gallagher, Heather M RouseThe Annals of Pharmacotherapy|November 2, 2014
β-lactam/β-lactamase inhibitor combinations: from then to nowKimberly A Toussaint, Jason C GallagherJournal of Pharmacy Practice|August 16, 2014
Beta-lactam hypersensitivity and cross-reactivityAdrienne T Terico, Jason C GallagherPharmacotherapy|September 8, 2015
Update on Treatment Options for Gonococcal InfectionsJason W Lancaster, Monica V Mahoney, Sana Mandal, et al.Pageof 9